Emerging Drugs and Formulations for Pain Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 10 October 2025 | Viewed by 1470
Special Issue Editors
Interests: obesity; pain; experimental pain treatment; physiopathology of pain; experimental therapeutics
Interests: pain; neuropathy; neuropharmacology; pain treatment; opioid drugs; cannabinoid-based medicine
Special Issue Information
Dear Colleagues,
The global burden of pain has increased in recent times, and although measuring pain is complicated, approximately 20% of the population suffers from pain of a chronic nature. In this regard, it is important to recognize that chronic pain damages the quality of life of patients, and in the same way, it results in a higher cost to private and public health systems. Although analgesic marketed drugs produce a significant release from pain, a considerable number of patients do not experience pain relief. Also, the side effects of these conventional drugs lead to the abandonment of pharmacological management of pain. Relief from pain is a human right; however, the existence of significant barriers such as the lack of individualized therapies, the increased opioid crisis, and the undertreated patients with difficult pain syndromes can make this process difficult. In response to overcoming the major barriers of pharmacological pain treatment, we are pleased to invite all researchers of preclinical and clinical areas to contribute to this Special Issue entitled “Emerging Drugs and Formulations for Pain Treatment”. Original and review articles on preclinical and clinical findings focused on new drug design, reformulations, combined therapies, drug targeting, nanomedicine, delivery and controlled-release systems for drugs, advanced pharmacogenomics and pharmacogenetics therapies, and improved pharmacokinetic and pharmacodynamics processes of analgesic drugs, which enhance the understanding of treatment and release of pain, are welcome. Research areas include (but are not limited to) chronic, neuropathic, nociplastic, oncologic, and rare syndromes of pain conditions and others.
We look forward to receiving your contributions.
Dr. Hector Isaac Rocha-González
Dr. Geovanna Nallely Quiñonez-Bastidas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- analgesia
- experimental pain treatment
- preclinical models
- pharmacotherapeutic management of pain
- new drugs in clinical trials
- drug development
- psychotropic drugs
- natural compounds
- neuropathic Pain
- chronic pain
- synthetic drugs
- new formulations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
